Cargando…
SUMO-modifying Huntington’s disease
Small ubiquitin-like modifiers, SUMOs, are proteins that are conjugated to target substrates and regulate their functions in a post-translational modification called SUMOylation. In addition to its physiological roles, SUMOylation has been implicated in several neurodegenerative diseases, such as Al...
Autores principales: | Soares, Ericks S., Prediger, Rui D., Brocardo, Patricia S., Cimarosti, Helena I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210482/ https://www.ncbi.nlm.nih.gov/pubmed/35746980 http://dx.doi.org/10.1016/j.ibneur.2022.03.002 |
Ejemplares similares
-
Effects of amyloid-β on protein SUMOylation and levels of mitochondrial proteins in primary cortical neurons
por: Soares, Ericks S., et al.
Publicado: (2022) -
Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model
por: McMillan, Laura E., et al.
Publicado: (2011) -
Advances in the development of SUMO specific protease (SENP) inhibitors
por: Kumar, Ashutosh, et al.
Publicado: (2015) -
The mechanism of degeneration of striatal neuronal subtypes in Huntington disease
por: Rikani, Azadeh A., et al.
Publicado: (2014) -
New Avenues for the Treatment of Huntington’s Disease
por: Kim, Amy, et al.
Publicado: (2021)